BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 4998366)

  • 1. [Anti-D treatment after mismatched transfusion: prevention of Rh sensitization].
    Schellong G; Grimm W
    Dtsch Med Wochenschr; 1970 Dec; 95(51):2555-9. PubMed ID: 4998366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic measures in the prevention of Rh sensitization with anti D immunoglobulin].
    Jung K
    Dtsch Med Wochenschr; 1969 Aug; 94(33):1654-5. PubMed ID: 4183534
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of Rh-sensitization with the use of anti-D gamma-globulin after delivery].
    Keserü TL; Kaiser G; Annus J
    Zentralbl Gynakol; 1971 Jan; 93(1):24-9. PubMed ID: 4102084
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of Rh sensitization using immunoglobulin anti-D].
    Stampfli K; de Muralt G
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1519-21. PubMed ID: 4983123
    [No Abstract]   [Full Text] [Related]  

  • 5. [IgG-Anti D prevention].
    Speiser P
    Wien Med Wochenschr; 1971 Sep; 121(36):615-7. PubMed ID: 4999917
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of Rh isoimmunization.
    Clarke CA
    Prog Med Genet; 1972; 8():169-223. PubMed ID: 4110995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improved prognosis of fetal erythroblastosis through the variation of prophylactic and therapeutic measures].
    Verron G; Radzuweit H; Schubert W; Brockmann J
    Dtsch Gesundheitsw; 1970 Oct; 25(40):1906-10. PubMed ID: 4991821
    [No Abstract]   [Full Text] [Related]  

  • 8. [Practical problems in prevention of Rh-sensitization with immunological methods].
    Althoff W; Schellong G; Stahl M
    Minerva Med; 1969 Jul; 60(59):2905-15. PubMed ID: 4978556
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fetomaternal transfusion, Rhesus immunization and prevention. II. Rhesus immunization and prevention].
    Helderweirt G
    Verh K Acad Geneeskd Belg; 1976; 38(3-4):79-134. PubMed ID: 826036
    [No Abstract]   [Full Text] [Related]  

  • 10. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993890
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is the prevention of sensitization of rhesus negative women possible?].
    Schneider J
    Landarzt; 1968 Mar; 44(9):443-6. PubMed ID: 4180650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary results of the use of anti-D immuno-gamma-globulin in the prevention of Rh factor isoimmunization].
    Gherardi A
    Ig Mod; 1970; 63(1):47-56. PubMed ID: 4991878
    [No Abstract]   [Full Text] [Related]  

  • 14. [The present status of prevention of Rh sensitization with anti-D sera].
    Preisler O; Schneider J
    Geburtshilfe Frauenheilkd; 1966 May; 26(5):732-4. PubMed ID: 4956775
    [No Abstract]   [Full Text] [Related]  

  • 15. Immuno-prevention of Rh hemolytic disease of the newborn.
    McConnell RB; Woodrow JC
    Annu Rev Med; 1974; 25():165-78. PubMed ID: 4132885
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylaxis of Rh sensitisation with anti-D immunoglobulin. Experiences in the hospital from 1968 to 1970].
    Rummel W; Ruh W; Dördelmann P
    Munch Med Wochenschr; 1971 Jan; 113(5):155-9. PubMed ID: 4993029
    [No Abstract]   [Full Text] [Related]  

  • 18. [Our preliminary experience in the field of serum prevention of anti-HDN hemolytic disease of the newborn by means of anti-D immunoglobulins].
    Arrotta U; Cardinale F; Sideri L
    Minerva Ginecol; 1972 Dec; 24(12):619-26. PubMed ID: 4211544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunoglobulin prophylaxis].
    Schneider J
    Wien Klin Wochenschr; 1970 May; 82(22):401-4. PubMed ID: 4998415
    [No Abstract]   [Full Text] [Related]  

  • 20. [Transfusion of blood incompatible with Rh factor: evolution and use of immunoglobulin anti-D].
    Almuna R; Testa E; Zeldis S; Monterríos E
    Rev Chil Obstet Ginecol; 1976; 41(5):267-73. PubMed ID: 829550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.